6 completed, 1 active not recruiting, 1 unknown, 1 withdrawn. 4 Phase 3, 2 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Not applicable | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Syringe: new trials by email Literature Review of Syringe trials Research Report on Syringe
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations NR082 Injection, Injection needle - Leber Hereditary Optic Neuropathy (LHON) | Phase 1 / Phase 2 | Active not recruiting | Neurophth Therapeutics Inc | 12 | 2023-05-22 | 2024-09-04 |
| Superiority of Epidural Placement Technique Using EpiFaith Syringe Syringe - Anesthesia | Not applicable | Withdrawn | Harvard Medical School (HMS and HSDM) | 2022-05-15 | 2023-07-21 | |
| Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome Teduglutide, Standard Medical Therapy, Syringe - Short Bowel Syndrome | Phase 3 | Completed | Shire | 10 | 2018-08-31 | 2021-05-11 |
| An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004 Teduglutide, Syringe, Needle - Short Bowel Syndrome | Phase 3 | Completed | Takeda | 11 | 2018-07-09 | 2023-03-15 |
| Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Teduglutide, Syringe, Needle - Short Bowel Syndrome | Phase 3 | Completed | Shire | 7 | 2018-07-06 | 2020-08-04 |
| Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) TED, SOC, Syringe - Short Bowel Syndrome | Phase 3 | Completed | Shire | 61 | 2017-01-09 | 2025-03-28 |
| Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic Control Pens Device, Syringe, Monitoring capillary blood glucose with blood glucose monitor, lancet tapes and capillary blood glucose tests (3 tests/day) - Diabetes | Phase 4 | Unknown | Hospital de Clinicas de Porto Alegre | 112 | 2015-05-01 | 2015-08-06 |
| Reciprocating Medical Devices - a Study of a New Safety Device Reciprocating Procedure Device (RPD) - AVANCA Re No. 1091001, conventional syringe - BD Ref 309604 - Osteoarthritis, Rheumatoid Arthritis | Not applicable | Completed | University of New Mexico | 437 | 2004-11-01 | 2016-03-02 |
| Rectal Sensory Training - A Study of Two Techniques Syringe Conditioning, Barostat Conditioning - Rectal Hyposensitivity, Constipation | Phase 2 | Completed | Augusta University | 70 | 2004-03-01 | 2014-09-17 |
Short Bowel Syndrome (4) · Arthritis, Rheumatoid (1) · Constipation (1) · Diabetes Mellitus (1) · Neoplasms (1) · Optic Atrophy, Hereditary, Leber (1) · Osteoarthritis (1) · Pain (1) · Thyroid Nodule (1) · Wounds and Injuries (1)
Shire (3) · Augusta University (1) · Harvard Medical School (HMS and HSDM) (1) · Hospital de Clinicas de Porto Alegre (1) · Neurophth Therapeutics Inc (1) · Takeda (1) · University of New Mexico (1)
United States (5) · Finland (2) · Italy (2) · Japan (2) · United Kingdom (2) · Belgium (1) · Brazil (1) · Canada (1) · France (1)
Satish Rao, Md, PhD (1) · Ticiana da Costa Rodrigues (1) · Wilmer L Sibbitt, Jr., MD (1)
PMID 16339287, PMID 16511940, PMID 17143968, PMID 17278943, PMID 17885154, PMID 18281176, PMID 19037606, PMID 19265345, PMID 19648304, PMID 21057794, PMID 21078710, PMID 21127362, PMID 21447197, PMID 21469942, PMID 21617556, PMID 22452536, PMID 34118981, PMID 37364133, PMID 38873891, PMID 41858082
2016 (1), 2017 (1)